Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Thematic (Sector/Industry)

United states Consumer discretionary / Thematic (Sector/Industry)

<ul><li>The clinical trial landscape in psychedelics has evolved significantly over the past five years and has seen significant developments and milestones achieved in the last year.</li><li>There are currently more than 50 active clinical trials investigating the therapeutic value of psychedelic-based compounds as part of a treatment regimen, which includes the more traditional psychotherapy intervention.</li><li>About 60% of these clinical investigations have advanced to Phase II and Phase III stage trials.</li></ul>

The clinical trial landscape in psychedelics has evolved significantly over the past five years and has seen significant developments and milestones achieved in the last year.There are currently more than 50 active clinical trials investigating the therapeutic value of psychedelic-based compounds as part of a treatment regimen, which includes the more traditional psychotherapy intervention.About 60% of these clinical investigations have advanced to Phase II and Phase III stage trials.

Shroom Shmooz - Overview of the Clinical Trial Landscape in Psychedelics